DART Ventures

DART Ventures is an investment firm focused on empowering early-stage Swiss and European founders to successfully enter and thrive in the US market. The firm strategically invests in breakthrough technologies that aim to positively impact global health and climate. They are mission-driven, believing that combining purpose with profit leads to significant impact, and offer a tailored 12-month program to guide startups on strategy, culture, fundraising, and US expansion.

The firm was founded in 2017 and is based out of Zurich, Switzerland, with an additional presence in San Francisco, California. DART Ventures was established with the belief that the world's most significant challenges can be addressed through innovative technologies and international collaboration. They aim to connect the robust European talent pool and research with US investors and market opportunities.

DART Ventures' portfolio includes 15 startups and has seen one exit. Notable investments span health and climate sectors, including companies like Impli (implantable bio-sensors), Orbillion Bio (sustainable cultivated meat), PeriVision (AI, virtual reality, and cloud for vision saving), Resmonics (acoustic lung symptom monitoring), and Testmate Health (at-home STD testing). The firm also supports companies like Bea Fertility, BottNeuro, Fluidsolids, Gaeastar, HealthCaters, Inergio, Una Health, VAY, Xsensio, and Zoe.

The leadership team includes Managing Partners Sophie Lamparter and Arijana Walcott. They are supported by a network of Venture Partners such as Doug Griffin, Priska Roesli, Walter Greenleaf, Aimée Leifer, Jasmine Kent, Gioia Deucher, and Christine Wyss, along with a broad group of experts and friends. This team provides extensive experience and a valuable network to assist portfolio companies in their growth and expansion efforts.